Showing results (1-10 of 422) with videos related to
Sort By:
Pageof 43
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 25, 2017
Use of FEV<sub>1</sub> in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcherRhonda Szczesniak, Sonya L Heltshe, Sanja Stanojevic, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2014
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftorSonya L Heltshe, Nicole Mayer-Hamblett, Jane L Burns, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2014
Early attained weight and length predict growth faltering better than velocity measures in infants with CFSonya L Heltshe, Drucy S Borowitz, Daniel H Leung, et al.American Journal of Respiratory and Critical Care Medicine|December 21, 2019
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical ImplicationsMarcus A Mall, Nicole Mayer-Hamblett, Steven M RoweJournal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 3, 2021
A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosisAlex Paynter, Umer Khan, Sonya L Heltshe, et al.American Journal of Epidemiology|June 25, 2024
Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an applicationMark N Warden, Sonya L Heltshe, Noah Simon, et al.American Journal of Respiratory and Critical Care Medicine|June 14, 2014
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosisSteven M Rowe, Sonya L Heltshe, Tanja Gonska, et al.Chest|January 25, 2017
Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV<sub>1</sub> < 30% of Predicted in the United StatesKathleen J Ramos, Bradley S Quon, Sonya L Heltshe, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 21, 2017
Biomarkers for cystic fibrosis drug developmentMarianne S Muhlebach, J P Clancy, Sonya L Heltshe, et al.Current Opinion in Pulmonary Medicine|July 15, 2017
Innovating cystic fibrosis clinical trial designs in an era of successful standard of care therapiesDonald R VanDevanter, Nicole Mayer-HamblettPageof 43